Delivery Order SPE2DB22D2006-SPE2DB24FW1AL
Award Date 6/11/24
Potential Completion Date 6/12/24
Potential Value $16K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of 4,565,153,938 units of Vyvanse 40 mg capsules to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, on a firm fixed-price basis with a ceiling value of $6,580.88. The contract has a period of performance through July 16, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery...
- This federal contract award is for the delivery of 4,565,005,875 units of Vyvanse 50 mg capsules to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $1,293.00 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office division on June 26, 2024, with an ultimate completion date of June 27, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of 4,565,099,639 units of the prescription drug Vyvanse (50 mg capsules) to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense (DoD). The contract, valued at $2,579.01, was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is a firm fixed-price Delivery Order with a completion date of July 10, 2024. Amerisourcebergen holds several...
- This federal contract award is for the delivery of 4,564,995,521 units of the pharmaceutical drug Vyvanse 40mg capsules to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to the corporate office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on a firm fixed-price basis with a ceiling value of $1,982.22 and a completion date of June 26, 2024. This appears to be a delivery order under a larger...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of 4,565,007,799 units of the prescription drug Vyvanse 60 mg capsule, valued at $2,821.52. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a subordinate agency of the Department of Defense (DoD), and has a completion date of June 27, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract...
- This federal contract award is for the delivery of 4,556,502,080 units of Vyvanse 30 mg capsules to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $15,800.93. The award is a delivery order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC...
- This federal contract award is for the supply of 4,564,604 units of the prescription medication Vyvanse 30mg capsules to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The $2,097.86 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies globally. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,359,320 units of Vyvanse 50 mg capsules. The contract has a ceiling value of $4,006.50 and is a firm-fixed price delivery order, with a period of performance through November 7, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award is for the delivery of Vyvanse 40 mg capsules to the Defense Logistics Agency (DLA), a major supplier of medical products and services to the U.S. Department of Defense. The contract was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a large pharmaceutical distribution company, and has a ceiling value of $2,952.43. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This is a federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, to provide 4,564,997,540 units of the medication Vyvanse 50 mg capsules to the Department of Defense (DoD). The contract has a ceiling value of $1,293.00 and is a Firm Fixed Price Delivery Order contract with a completion date of June 26, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support...